References
- Moss AJ , ZarebaW, HallWJet al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. Med. , 346, 877–883 (2002).
- Bardy GH , LeeKL, MarkDBet al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med. , 352, 225–237 (2005).
- McMurray JJ , AdamopoulosS, AnkerSDet al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur. Heart J. , 33, 1787–1847 (2012).
- Kaufmann BA , MinSY, GoetschalckxKet al. How reliable are left ventricular ejection fraction cut offs assessed by echocardiography for clinical decision making in patients with heart failure? Int. J. Cardiovasc. Imaging , 29(3), 581–588 (2013).
- Iles L , PflugerH, LefkovitsLet al. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J. Am. Coll. Cardiol. , 57, 821–828 (2011).
- Hager CS , JainS, BlackwellJ, CulpB, SongJ, ChilesCD. Effect of renal function on survival after implantable cardioverter defibrillator placement. Am. J. Cardiol., 106, 1297–1300 (2010).
- Koller MT , SchaerB, WolbersM, SticherlingC, BucherHC, OsswaldS. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study. Circulation, 117, 1918–1926 (2008).
- Berger R , HuelsmanM, StreckerKet al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation , 105, 2392–2397 (2002).
- Vrtovec B , DelgadoR, ZewailA, ThomasCD, RichartzBM, RadovancevicB. Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure. Circulation, 107, 1764–1769 (2003).
- Bayes-Genis A , VazquezR, PuigTet al. Left atrial enlargement and NT-proBNP as predictors of sudden cardiac death in patients with heart failure. Eur J. Heart Fail. , 9, 802–807 (2007).
- Verma A , KilicaslanF, MartinDOet al. Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies. Heart , 92, 190–195 (2006).
- Scott PA , BarryJ, RobertsPR, MorganJM. Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis. Eur J. Heart Fail., 11, 958–966 (2009).
- Vrtovec B , KnezevicI, PoglajenG, SebestjenM, OkrajsekR, HaddadF. Relation of B-type natriuretic peptide level in heart failure to sudden cardiac death in patients with and without QT interval prolongation. Am. J. Cardiol., 111(6), 886–890 (2012).
- Maeder MT , MarianiJA, KayeDM. Hemodynamic determinants of myocardial B-type natriuretic peptide release: relative contributions of systolic and diastolic wall stress. Hypertension, 56, 682–689 (2010).
- Maeder MT , MuellerC, PfistererME, BuserPT, Brunner-La Rocca HP. Use of B-type natriuretic peptide outside of the emergency department. Int. J. Cardiol., 127, 5–16 (2008).
- Bode-Schnurbus L , BockerD, BlockMet al. QRS duration: a simple marker for predicting cardiac mortality in ICD patients with heart failure. Heart , 89, 1157–1162 (2003).
- Breidthardt T , ChristM, MattiMet al. QRS and QTc interval prolongation in the prediction of long-term mortality of patients with acute destabilised heart failure. Heart , 93, 1093–1097 (2007).